Addendum to British Society for Haematology guidelines on investigation and management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct acting oral anticoagulants.

Arachchillage, Deepa R JGomez, KeithAlikhan, RazaAnderson, Julia A MLester, WillLaffan, Mike2025-05-072025-05-072020-01-13Arachchillage DRJ, Gomez K, Alikhan R, Anderson JAM, Lester W, Laffan M; British Society for Haematology Haemostasis and Thrombosis Taskforce. Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct acting oral anticoagulants. Br J Haematol. 2020 Apr;189(2):212-215. doi: 10.1111/bjh.16308. Epub 2020 Jan 130007-10481365-214110.1111/bjh.1630831943138http://hdl.handle.net/20.500.14200/7678No abstract availableenHaematologyAddendum to British Society for Haematology guidelines on investigation and management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct acting oral anticoagulants.Other